ArticlePloS one2026
Investigating the anticancer potential of phytochemicals from the mangrove Rhizophora mucronata as inhibitors of lung cancer-associated proteins: Insights from multiscale computational and in silico analyses.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung cancer remains the leading cause of cancer-related mortality worldwide, with a five-year survival rate of approximately 20-25% despite advances in targeted therapy and immunotherapy. There is a continuous need for novel, low-toxicity compounds capable of modulating key oncogenic pathways in non-small cell lung cancer (NSCLC). Mangrove ecosystems are rich reservoirs of bioactive phytochemicals, yet the inhibitory potential of compounds from Rhizophora mucronata against validated lung cancer-associated proteins has not been systematically explored using multi-scale computational approaches. This study employed an integrated computational pipeline to evaluate 14 phytochemicals from R. mucronata. Density Functional Theory (DFT) calculations at the B3LYP/6-31G* level were performed to characterize electronic properties of the ligands. Molecular docking studies were conducted using both AutoDock Vina (PyRx) and Schrödinger Glide against the Keap1 Kelch domain (PDB 1X2J) and the YEATS2 YEATS domain (PDB 5XNV). Top-ranked complexes were subjected to 100-ns molecular dynamics (MD) simulations in Desmond, and pharmacokinetic and toxicity profiles were predicted using SwissADME and pkCSM. Among the screened compounds, ligand L10 (cyclohexane-1,2,3,4,5,6-hexaol) exhibited the smallest HOMO-LUMO energy gap (0.36 eV), favorable binding affinities (Glide score of -7.789 kcal/mol against 1X2J), multiple hydrogen-bonding interactions, and stable complex behavior during MD simulations (Cα RMSD < 3 Å). Several other ligands (L02, L05, and L07) also displayed promising profiles. Most compounds complied with Lipinski's rule of five and showed acceptable predicted ADMET properties. These preliminary findings suggest that Rhizophora mucronate -derived phytochemicals, particularly L10, are promising candidates for further experimental evaluation as modulators of Keap1 and YEATS2 in lung cancer. This study provides a computational framework for prioritizing natural product leads from mangrove species for subsequent in vitro and in vivo validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.